• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CeriBell, Inc. - Common Stock (NQ:CBLL)

    26.47 +1.21 (+4.79%)
    Delayed Quote Updated: 1:14 PM EDT, Oct 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 199,366
    Open 25.35
    Bid (Size) 26.41 (100)
    Ask (Size) 26.51 (200)
    Prev. Close 25.26
    Today's Range 24.89 - 26.53
    52wk Range 10.85 - 25.63
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis
    New clearance to further simplify bedside EEG interpretation and enable more informed interventions for patients of all ages across multiple indications 
    From Ceribell
    Via GlobeNewswire
    News headline image
    CeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric Push ↗
    CeriBell (NASDAQ:CBLL) outlined its plans to expand its brainwave-monitoring platform beyond seizure detection, pointing to new products for delirium, pediatric patients and eventually stroke as it... 
    Via MarketBeat

    Performance

    52-Week Range
    26.47
    10.8552W Low 25.6352W High
    1 Week
    22.621W Low 25.271W High

    CeriBell, Inc. - Common Stock (CBLL) traded between $10.85 and $25.63 over the past 52 weeks and last traded at $26.47. Over the past week it ranged between $22.62 and $25.27.

    Past 12 Months
    +8.8%
    +8.8%
    +35.6%
    +38.3%
    +24.3%
    +121.0%
    1W +$2.13
    1M +$2.14
    3M +$6.95
    6M +$7.33
    YTD +$5.17
    1Y +$14.49

    CBLL was +121.0% over the past year, +38.3% over six months, +24.3% year to date, +8.8% in the last week.

    12 Months vs Market
    CBLL
    +121.0%
    DIA
    +12.0%
    SPY
    +17.2%
    QQQ
    +23.3%
    IWM
    +13.1%

    Over the past 12 months CBLL returned +121.0% versus DIA (Dow) +12.0%, SPY (S&P 500) +17.2%, QQQ (Nasdaq 100) +23.3% and IWM (Russell 2000) +13.1%.

    Volume & Liquidity 0.53× 3-mo avg
    Today 199,366 3-mo avg 377.5K
    1W
    362.7K
    1M
    369.7K
    3M
    377.5K
    6M
    354.8K
    YTD
    344.7K
    1Y
    368.1K

    CBLL most recently traded 199,366 shares against a 3-month average daily volume of 377.5K.

    More News

    Read More
    News headline image
    CeriBell (CBLL) Q2 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings Intellectual Property World Trade
    Ceribell Inc (NASDAQ:CBLL) Q1 Revenue Beats Estimates, Net Loss Widens, Full-Year Guidance Raised ↗
    Via Chartmill
    Ceribell Inc (NASDAQ:CBLL) Reports Strong Q4 Revenue Beat and Provides 2026 Outlook ↗
    Via Chartmill
    News headline image
    CeriBell Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings World Trade
    News headline image
    Ceribell Reports Second Quarter 2026 Financial Results
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference
    From Ceribell
    Via GlobeNewswire
    News headline image
    CeriBell Sees ‘Early Innings’ Growth as Hospital Accounts and Usage Hit Records ↗
    Via MarketBeat
    News headline image
    CeriBell Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    CeriBell (CBLL) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    Topics World Trade
    News headline image
    Ceribell Reports First Quarter 2026 Financial Results
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Report First Quarter 2026 Financial Results on May 11, 2026
    From Ceribell
    Via GlobeNewswire
    News headline image
    CeriBell (CBLL) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings World Trade
    News headline image
    Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Participate in Upcoming March Investor Conferences
    From Ceribell
    Via GlobeNewswire
    News headline image
    Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
    From Ceribell
    Via GlobeNewswire
    News headline image
    AI Diagnostics: The End of the High-Cost Imaging Era
    From Equity Insider
    Via GlobeNewswire

    Frequently Asked Questions

    Is CeriBell, Inc. - Common Stock publicly traded?
    Yes, CeriBell, Inc. - Common Stock is publicly traded.
    What exchange does CeriBell, Inc. - Common Stock trade on?
    CeriBell, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for CeriBell, Inc. - Common Stock?
    The ticker symbol for CeriBell, Inc. - Common Stock is CBLL on the Nasdaq Stock Market
    What is the current price of CeriBell, Inc. - Common Stock?
    The current price of CeriBell, Inc. - Common Stock is 26.47
    When was CeriBell, Inc. - Common Stock last traded?
    The last trade of CeriBell, Inc. - Common Stock was at 10/13/26 01:14 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.